The team

Thomas Harth

Partner

Location

Barcelona

Contact

Contact Thomas

Biography

Thomas is responsible for identifying and evaluating investment opportunities at Ysios Capital.

Prior to joining Ysios, Thomas was Senior Associate at Gimv within the Health & Care team working out of the Antwerp office. He was focused on early-stage Life Sciences investments. Thomas co-led the investments in Anjarium biosciences and Kinaset Therapeutics and was involved with portfolio companies Fire1, ONWARD (Euronext – ONWD), Biotalys (Euronext – BTLS), JenaValve (sold to Edwards), and Breath Therapeutics (sold to Zambon).

Thomas holds a master’s degree in Bioengineering and Applied Economics, both from the University of Ghent.

Board positions

Thomas is a Board Member at Tagworks PharmaceuticalsMemo Therapeutics and Anaconda Biomed.

 
Для тех, кто ищет безопасную и удобную платформу, Joycasino официальный сайт станет лучшим выбором благодаря акционным предложениям и огромному выбору игр.